Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018129 | PMC |
| http://dx.doi.org/10.3324/haematol.2019.242453 | DOI Listing |
Publication Analysis
Top Keywords
bi38-3 novel
4
novel cd38/cd3
4
cd38/cd3 bispecific
4
bispecific t-cell
4
t-cell engager
4
engager low
4
low toxicity
4
toxicity treatment
4
treatment multiple
4
multiple myeloma
4
Similar Publications
Bi38-3 is a novel CD38/CD3 bispecific T-cell engager with low toxicity for the treatment of multiple myeloma.
Haematologica
April 2021
Institut de recherche Saint-Louis, Inserm U976.